有关疫苗审批的翻译

来源:百度知道 编辑:UC知道 时间:2024/05/31 06:41:39
1.Targeted amount of active components in the final formulations with the lot numbers and volumes of bulks concentrates.
2.50% end points
3.Then the protocols are routed to the various individuals within the NCLs/NRAs that had already been determined based on their expertise.
4.Lot number(s), passage number of the master and/or working seed(s) and working cell bank are within the acceptable ranges which have been validated and approved
回答部分也可以!!

太专业,只能这样了

1.最后配方与批号和数量块集中针对大量的活动元件。
2.2.50 %终结点
3.然后议定书通过NCLs / NRAs发送给那些已经在他们的专业知识上做出确认的个人。
4.批号,主要传代数和种还有细胞库在可以接受的范围内已被确认和批准